Results 261 to 270 of about 164,371 (301)
IDAP: an integrated literature- and knowledge-graph-driven evidence prioritization pipeline for precision oncology. [PDF]
Ryu Y, Jeong HE, An JY.
europepmc +1 more source
Antibody-drug conjugates for precision oncology in cholangiocarcinoma. [PDF]
Prasher P, Sharma M.
europepmc +1 more source
OnCorr: A pan-cancer mRNA-protein correlation tool for precision oncology. [PDF]
Nawaz U +7 more
europepmc +1 more source
Precision Oncology 2.0: Guiding Magic Bullets With Expression-Based Liquid Biopsy. [PDF]
Gulati GS +3 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Enabling Precision Oncology Through Precision Diagnostics
Annual Review of Pathology: Mechanisms of Disease, 2020Genomic testing enables clinical management to be tailored to individual cancer patients based on the molecular alterations present within cancer cells. Genomic sequencing results can be applied to detect and classify cancer, predict prognosis, and target therapies. Next-generation sequencing has revolutionized the field of cancer genomics by enabling
Noah A Brown
exaly +3 more sources
Rapid learning for precision oncology
Nature Reviews Clinical Oncology, 2014The emerging paradigm of Precision Oncology 3.0 uses panomics and sophisticated methods of statistical reverse engineering to hypothesize the putative networks that drive a given patient's tumour, and to attack these drivers with combinations of targeted therapies.
Jeff Shrager
exaly +3 more sources
Clinician Perspectives on Communication and Implementation Challenges in Precision Oncology
AIM: To describe patient communication challenges encountered by oncology clinicians, which represent a fundamental barrier to implementing precision oncology.
Jada G Hamilton +2 more
exaly +2 more sources
The European Society for Medical Oncology (ESMO) Precision Medicine Glossary
Precision medicine is rapidly evolving within the field of oncology and has brought many new concepts and terminologies that are often poorly defined when first introduced, which may subsequently lead to miscommunication within the oncology community ...
C Le Tourneau +2 more
exaly +2 more sources

